Paper Details

  1. Home
  2. Paper Details

Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia.

Author: CorrellChristoph U, HobartMary, KaneJohn M, OuyangJohn, SkubanAleksandar, WeillerEmmanuelle, WeissCatherine

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Brexpiprazole, a serotonin-dopamine activity modulator, was well-tolerated in patients with schizophrenia, with a favorable safety profile and low rates of important adverse events such as akathisia, sedation, weight gain, or QTc prolongation.
Paper Details　
Original Abstract of the Article :
Second-generation antipsychotics have demonstrated efficacy for patients with schizophrenia but are associated with wide-ranging side effects. Brexpiprazole, a serotonin-dopamine activity modulator, has demonstrated efficacy in adult patients with schizophrenia. This paper provides an overview of th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.schres.2016.04.013

データ提供：米国国立医学図書館（NLM）

Overview of Short- and Long-Term Tolerability and Safety of Brexpiprazole in Patients with Schizophrenia

This research delves into the field of [schizophrenia treatment], an area where finding effective and safe medications is crucial for improving patient well-being. The study examines the [tolerability and safety profile of brexpiprazole], a novel [serotonin-dopamine activity modulator], over both [short- and long-term durations]. The authors found that [brexpiprazole was well-tolerated] with a [favorable safety profile], exhibiting [low rates of significant adverse events] commonly associated with other antipsychotics. This study provides compelling evidence supporting the [potential of brexpiprazole as a safe and effective treatment option for schizophrenia].

Navigating the Sands of Schizophrenia Treatment: Brexpiprazole Shows Promise

This research offers a glimmer of hope for individuals living with schizophrenia. The study’s findings suggest that brexpiprazole, a new antipsychotic, exhibits a favorable tolerability and safety profile, making it a potential alternative for those seeking effective and well-tolerated treatment options.

A Journey Through the Mind: Exploring Brexpiprazole's Potential in Schizophrenia Treatment

The desert is a vast and enigmatic landscape, much like the human mind. Understanding the complexities of schizophrenia and finding safe and effective treatments is a daunting task. This study offers a roadmap for navigating this challenging terrain, highlighting the potential of brexpiprazole as a valuable tool for managing this complex mental health condition.

Dr.Camel's Conclusion

This study demonstrates the favorable tolerability and safety profile of brexpiprazole in patients with schizophrenia. Its low rates of significant adverse events compared to existing antipsychotics make it a promising treatment option for patients seeking effective and well-tolerated medication.
Date :
  1. Date Completed 2018-01-05
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

27188270

DOI: Digital Object Identifier

10.1016/j.schres.2016.04.013

Related Literature

Article Analysis
・Side Effects of brexpiprazole
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.